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RESUMO – Dermatofibromas eruptivos múltiplos (DEM) é uma condição rara caracterizada pelo aparecimento de múltiplos 
dermatofibromas num curto período. DEM está habitualmente associada a alterações na imunidade e o seu diagnóstico deve 
levar a um rastreio adequado de patologias subjacentes, incluíndo a infeção por VIH e lupus eritematoso. Reportamos um 
caso de DEM numa doente do sexo feminino VIH positiva, possivelmente associada à diminuição da contagem de linfócitos 
T CD4+ e aumento da carga viral.
PALAVRAS-CHAVE – Histiocitoma Fibroso Benigno; Infecções por VIH; Neoplasias da Pele.
Multiple Eruptive Dermatofibromas in a Patient with 
HIV infection 
ABSTRACT – Multiple eruptive dermatofibromas is a rare event characterized by the appearance multiple dermatofibromas in few 
months. It is usually associated with immunodysregulation/immunosuppression. An appropriate work-up of underlying diseases must 
be done after this diagnosis, including search for HIV infection and lupus erythematosus. We present a case of multiple eruptive 
dermatofibromas in a female patient with HIV infection, possibly associated with a decrease in the CD4+ T cell count and viral 
load increase. 
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INTRODUCTION
Dermatofibromas (DF) are benign fibrohistiocytic tumors, 
most often solitary not associated with internal disease, that 
usually appear on the legs of young women.1 Multiple erupti-
ve dermatofibromas (MEDF) is a rare event, first described by 
Baraf and Shapiro in 1970, characterized by the appearance 
of multiple lesions in a few months.2,3 The definition of MEDF 
is arbitrary, but is generally accepted as the presence of five 
to eight dermatofibromas in less than a 4-month period.4 The 
short period of time for the appearance of lesions is more im-
portant than the number of lesions.5 MEDF have been repor-
ted in the setting of autoimmune disease, patients treated with 
immunosuppressive drugs and in the course of HIV infection 
or neoplasms.1
CASE REPORT
A 42-year-old woman from Angola, Fitzpatrick type VI, 
known as HIV positive for 14 years, was observed with a 
4-year history of several asymptomatic and hyperpigmented 
cutaneous lesions in the lower extremities, that appeared within 
a period of a few months. Examination of lower extremities 
revealed multiple dark-brown firm non-tender papules, with 
2-8 mm in diameter (Fig.s 1 and 2). The “dimple sign” was de-
monstrated on each lesion. By consulting the clinical process it 
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was possible to verify that when lesions began there was a de-
crease in the CD4+ T cell count (9 cells/mm3) and an increase 
in the viral load (454300 copies/mL). Afterwards, there was a 
change in the highly active antiretroviral therapy (HAART), with 
addiction of dolutegravir to etravirine, ritonavir and darunavir. 
CD4 count increased to 174.6 cells/mm3, and at the moment 
of the consultation there were 746.5 CD4+ cells/mm3 and the 
viral load was below the detection threshold.
The excisional biopsy showed a nodular dermal prolifera-
tion, predominantly of spindle-shaped fibroblasts and myofi-
broblasts arranged as short intersecting fascicles, consistent 
with dermatofibroma (Fig.s 3 and 4).
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Figure 1 - Multiple dark-brown firm non-tender papules in the lower limbs, with 2-8 mm in diameter.
Figure 2 - Multiple dark-brown firm non-tender papules around the knee, with 2-8 mm in diameter.
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The combination of multiple dermatofibromas that appear 
in few months associated with an imunne dysregulated status 
lead to the diagnosis of multiple eruptive dermatofibromas. 
DISCUSSION
The clinical and histological features of MEDF did not differ 
from the solitary form. On histopathology the feature is simi-
lar to the solitary form, characterized by a well-circumscribed 
dermal tumour that is comprised of plump, spindle cells with 
collagen trapping at the outer edges of the lesion. Overlying 
epidermal hyperplasia and hyperpigmentation of the basal 
layer is frequent.
In addition to the number of dermatofibromas, the abrupt 
onset of lesions in a short period of time characterizes this diag-
nosis. MEDF are usually more prominent in legs, but may occur 
in other locations, including the hands.6 Comparing with clas-
sic dermatofibromas, MEDF extend more often to the trunk.7 
MEDF are more frequent in immunosuppressed patients, but 
the number of dermatofibromas is variable and is not rela-
ted with the rate of immunosuppression.2 The condition is self-
-limiting and independent of the underlying disease evolution. 
The majority of patients have an underlying disease, and 66% 
of the cases are associated to immune-mediated diseases with 
systemic lupus erythematous and HIV infection/AIDS among 
the more frequent associated pathologies.1 Other associated 
diseases include dermatomyositis, Sjögren syndrome, myasthe-
nia gravis, mycosis fungoides, hematologic malignancy, and 
medication, including: cyclophosphamide, methotrexate, glu-
cocorticoids, azathioprine and anti-TNF-a. There are cases as-
sociated with changes in the HAART,8 yet it is questionable if it 
was consequence of the medication or consequence of an im-
mune reconstitution. In our case, chronological evolution point 
to HIV infection as the associated condition. No new dermatofi-
bromas appeared with the change in HAART. In the past, infec-
tious agents have been proposed an etiologic factor for MEDF, 
in a context of immune reconstitution inflammatory syndrome.9 
Recently it was proposed that dermatofibroma represents an 
abortive immunoreactive process mediated by dermal dendri-
tic cells. According to this hypothesis, development of MEDF in 
immunodeficiency states could be facilitated by the inhibition 
of down-regulatory T cells.10 In immunocompromised patients, 
the condition can be clinically confused with other papular le-
sions such as Kaposi’s sarcoma and bacillary angiomatosis. 
The diagnosis of MEDF should be considered a consequence of 
immune dysregulation, and an appropriate work-up to rule out 
an autoimmune disorder, connective-tissue diseases, hemato-
logic malignancies or HIV infection must be done.1
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Figure 3 - Histopathology of the lesion. Nodular dermal proliferation, 
predominantly of spindle-shaped fibroblasts and myofibroblasts arranged 
as short intersecting fascicles. (H&E, 40x).
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Figure 4 - Detail of histopathology showing plump spindle cells with 
collagen trapping. (H&E, 400x).
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